- Investing Ideas
- /
- French Pharmaceuticals & Biotech High Growth Potential Companies
French Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Apr 17, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
20 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
OSE | €4.88 | 4.8% | -0.4% | €105.1m | €7.15 | PS47.2x | E92.9% | n/a | ||
ALDVI | €1.70 | 6.1% | -60.3% | €20.9m | €6.90 | PS6.4x | E118.1% | n/a | ||
IPH | €2.16 | -7.1% | -24.7% | €174.6m | €6.27 | PS2.8x | E30.0% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
ADOC | €8.50 | -7.1% | 184.3% | €119.7m | €9.70 | PS11x | E84.1% | n/a | ||
VLA | €3.60 | -7.4% | -26.2% | €499.6m | €8.95 | PS3.3x | E50.9% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
MEDCL | €11.36 | 22.5% | 25.9% | €326.6m | €16.75 | PS23.1x | E67.9% | n/a | ||
ALBPS | €0.0023 | -17.9% | -93.2% | €2.6m | n/a | PE-0.2x | E56.2% | n/a | ||
ALVAL | €3.84 | -3.5% | 5.5% | €60.6m | €10.07 | PS13.8x | E63.4% | n/a | ||
GNFT | €3.18 | -1.9% | -8.0% | €157.8m | €9.38 | PS4.6x | E54.7% | n/a | ||
ALACT | €3.99 | 17.4% | -31.2% | €52.4m | €10.00 | PB142.4x | E81.5% | n/a | ||
DBV | €1.27 | -4.7% | -57.5% | €122.2m | €4.78 | PS8.3x | E53.3% | n/a | ||
DIM | €248.60 | -1.6% | -10.9% | €24.2b | €264.64 | PE78.1x | E21.8% | 0.3% | ||
ALPAT | €9.80 | -2.0% | -23.4% | €10.7m | €11.50 | PS4.6x | E92.7% | n/a | ||
ALERS | €15.26 | -5.6% | -6.2% | €156.0m | €30.00 | PE32.5x | E36.3% | n/a | ||
PHXM | €2.95 | 1.2% | -67.5% | €17.9m | €6.85 | PS13.5x | E144.6% | n/a | ||
ERF | €58.92 | -1.9% | -3.1% | €11.3b | €59.28 | PE44.1x | E19.7% | 0.8% | ||
VIRP | €368.50 | 4.8% | 23.0% | €3.1b | €361.56 | PE25.4x | E11.4% | 0.4% | ||
EAPI | €2.67 | -9.2% | -75.7% | €253.6m | €4.72 | PB0.3x | E85.2% | n/a |
Page 1 of 1